Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies for modifying drug residence time and ocular bioavailability to decrease treatment frequency for back of the eye diseases
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 16, Issue 1, Pages 43-57
Publisher
Informa UK Limited
Online
2018-11-29
DOI
10.1080/17425247.2019.1553953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug delivery devices for retinal diseases
- (2018) Hirokazu Kaji et al. ADVANCED DRUG DELIVERY REVIEWS
- Theoretical Insights into the Retinal Dynamics of Vascular Endothelial Growth Factor in Patients Treated with Ranibizumab, Based on an Ocular Pharmacokinetic/Pharmacodynamic Model
- (2018) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT
- (2018) Srinivas R. Sadda et al. OPHTHALMOLOGY
- Safety Assessment of Formulation Vehicles Following Intravitreal Administration in Rabbits
- (2018) Shirley A. Aguirre et al. PHARMACEUTICAL RESEARCH
- Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
- (2018) Hemal Mehta et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Binding to Ocular Albumin as a Half-Life Extension Principle for Intravitreally Injected Drugs: Evidence from Mechanistic Rat and Rabbit Studies
- (2017) Holger Fuchs et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Ocular Pharmacokinetics of Therapeutic Antibodies Given by Intravitreal Injection: Estimation of Retinal Permeabilities Using a 3-Compartment Semi-Mechanistic Model
- (2017) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Pharmacokinetic aspects of retinal drug delivery
- (2017) Eva M. del Amo et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Recent developments in age-related macular degeneration: a review
- (2017) Waseem Al-Zamil et al. Clinical Interventions in Aging
- Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro
- (2016) Eda I. Altiok et al. BIOMATERIALS
- Biochemical analysis of the living human vitreous
- (2016) Jan Kokavec et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Current advances in the treatment of neovascular age-related macular degeneration
- (2016) Victor M. Villegas et al. Expert Opinion on Drug Delivery
- How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches
- (2016) Vibhuti Agrahari et al. Expert Opinion on Drug Delivery
- Recent perspectives on the delivery of biologics to back of the eye
- (2016) Mary Joseph et al. Expert Opinion on Drug Delivery
- Single ocular injection of a sustained-release anti -VEGF delivers 6 months pharmacokinetics and efficacy in a primate laser CNV model
- (2016) Peter Adamson et al. JOURNAL OF CONTROLLED RELEASE
- Posterior Segment Drug Delivery Devices: Current and Novel Therapies in Development
- (2016) Pooja Bansal et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
- (2016) Peter L. Turecek et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Mechanistic Model of the Intravitreal Pharmacokinetics of Large Molecules and the Pharmacodynamic Suppression of Ocular Vascular Endothelial Growth Factor Levels by Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration
- (2016) Laurence A. Hutton-Smith et al. MOLECULAR PHARMACEUTICS
- Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab
- (2016) Whitney Shatz et al. MOLECULAR PHARMACEUTICS
- Fit for the Eye: Aptamers in Ocular Disorders
- (2016) Daniel W. Drolet et al. Nucleic Acid Therapeutics
- Biodegradable Tetra-PEG Hydrogels as Carriers for a Releasable Drug Delivery System
- (2015) Jeff Henise et al. BIOCONJUGATE CHEMISTRY
- Ranibizumab Prefilled Syringes: Benefits of Reduced Syringe Preparation Times and Less Complex Preparation Procedures
- (2015) Eric Souied et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system
- (2015) Feiyan Ma et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development
- (2015) Eva M. del Amo et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics
- (2015) Michael L. Lovett et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation
- (2015) Mohammad Ali Sadiq et al. Expert Opinion On Drug Safety
- Advances in pharmacotherapy for wet age-related macular degeneration
- (2015) Martina Santarelli et al. EXPERT OPINION ON PHARMACOTHERAPY
- An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease
- (2015) Binbin Xie et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment
- (2015) Reyhaneh Varshochian et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Light-responsive nanoparticle depot to control release of a small molecule angiogenesis inhibitor in the posterior segment of the eye
- (2015) Viet Anh Nguyen Huu et al. JOURNAL OF CONTROLLED RELEASE
- Investigation of Fragment Antibody Stability and Its Release Mechanism from Poly(Lactide-co-Glycolide)-Triacetin Depots for Sustained-Release Applications
- (2015) Debby P. Chang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Branched Polymer–Drug Conjugates for Multivalent Blockade of Angiotensin II Receptors
- (2015) Robert Hennig et al. MOLECULAR PHARMACEUTICS
- Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies
- (2015) Leilei Zhang et al. PLoS One
- Molecular pathogenesis of retinal and choroidal vascular diseases
- (2015) Peter A. Campochiaro PROGRESS IN RETINAL AND EYE RESEARCH
- PEGylated Biopharmaceuticals
- (2015) Inge A. Ivens et al. TOXICOLOGIC PATHOLOGY
- Injectable Chemically Crosslinked Hydrogel for the Controlled Release of Bevacizumab in Vitreous: A 6-Month In Vivo Study
- (2015) Yu Yu et al. Translational Vision Science & Technology
- Ophthalmic statistics note 5: diagnostic tests—sensitivity and specificity
- (2014) Luke J Saunders et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
- (2014) Jennifer I Lim et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration
- (2014) Frank G Holz et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans—PK/PD and Safety
- (2014) R L O’Connor-Semmes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Implants for drug delivery to the posterior segment of the eye: A focus on stimuli-responsive and tunable release systems
- (2014) M. Naveed Yasin et al. JOURNAL OF CONTROLLED RELEASE
- Comparison of Binding Characteristics and In Vitro Activities of Three Inhibitors of Vascular Endothelial Growth Factor A
- (2014) Jihong Yang et al. MOLECULAR PHARMACEUTICS
- Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
- (2014) Mark Humayun et al. Translational Vision Science & Technology
- A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults
- (2013) Gabriel J. Robbie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intravitreal injections at the Massachusetts Eye and Ear Infirmary: analysis of treatment indications and postinjection endophthalmitis rates
- (2013) Miriam Englander et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ranibizumab for exudative AMD in a clinical setting: differences between 2007 and 2010
- (2013) Salomon Y. Cohen et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Mechanisms of age-related macular degeneration and therapeutic opportunities
- (2013) Menno van Lookeren Campagne et al. JOURNAL OF PATHOLOGY
- Trehalose Limits BSA Aggregation in Spray-Dried Formulations at High Temperatures: Implications in Preparing Polymer Implants for Long-Term Protein Delivery
- (2013) Karthikan Rajagopal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanoparticles in Porous Microparticles Prepared by Supercritical Infusion and Pressure Quench Technology for Sustained Delivery of Bevacizumab
- (2013) Sarath K. Yandrapu et al. MOLECULAR PHARMACEUTICS
- High Molecular Weight Polyethylene Glycol Cellular Distribution and PEG-associated Cytoplasmic Vacuolation Is Molecular Weight Dependent and Does Not Require Conjugation to Proteins
- (2013) Daniel G. Rudmann et al. TOXICOLOGIC PATHOLOGY
- MEMS-enabled implantable drug infusion pumps for laboratory animal research, preclinical, and clinical applications
- (2012) Ellis Meng et al. ADVANCED DRUG DELIVERY REVIEWS
- Intraocular Pharmacokinetics of Ranibizumab Following a Single Intravitreal Injection in Humans
- (2012) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
- (2012) Nicholas Papadopoulos et al. ANGIOGENESIS
- Aflibercept (VEGF Trap-eye): the newest anti-VEGF drug
- (2012) Michael W Stewart BRITISH JOURNAL OF OPHTHALMOLOGY
- Pharmacokinetic analysis of multi PEG–theophylline conjugates
- (2012) Mario Grassi et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Pharmacokinetic Properties of Intravitreal I-124-Aflibercept in a Rabbit Model Using PET/CT
- (2012) John B. Christoforidis et al. CURRENT EYE RESEARCH
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
- (2012) Jeffrey S. Heier et al. OPHTHALMOLOGY
- Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds
- (2012) Heidi Kidron et al. PHARMACEUTICAL RESEARCH
- Effect of Needle Type and Injection Technique on Pain Level and Vitreal Reflux in Intravitreal Injection
- (2011) Eduardo B. Rodrigues et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study
- (2011) David M. Brown et al. OPHTHALMOLOGY
- Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration
- (2011) K. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ocular Drug Delivery
- (2010) Ripal Gaudana et al. AAPS Journal
- Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
- (2010) Amy E. Green-Simms et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides
- (2010) B.-J. Kim et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and Safety of Monthly versus Quarterly Ranibizumab Treatment in Neovascular Age-related Macular Degeneration: The EXCITE Study
- (2010) Ursula Schmidt-Erfurth et al. OPHTHALMOLOGY
- Intravitreal poly(l-lactide) microparticles sustain retinal and choroidal delivery of TG-0054, a hydrophilic drug intended for neovascular diseases
- (2010) Namdev B. Shelke et al. Drug Delivery and Translational Research
- Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration
- (2009) S. Cherepanoff et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Ophthalmic Drug Delivery: Development and Regulatory Considerations
- (2009) GD Novack CLINICAL PHARMACOLOGY & THERAPEUTICS
- PEG-modified biopharmaceuticals
- (2009) Pascal Bailon et al. Expert Opinion on Drug Delivery
- New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis
- (2009) Laure Lajavardi et al. JOURNAL OF CONTROLLED RELEASE
- Inner Limiting Membrane Barriers to AAV-mediated Retinal Transduction From the Vitreous
- (2009) Deniz Dalkara et al. MOLECULAR THERAPY
- PREPARATION, CHARACTERIZATION, AND IN VIVO EVALUATION OF NANOLIPOSOMES-ENCAPSULATED BEVACIZUMAB (AVASTIN) FOR INTRAVITREAL ADMINISTRATION
- (2009) MAJID ABRISHAMI et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Intraocular Pharmacokinetics of Bevacizumab After a Single Intravitreal Injection in Humans
- (2008) Tim U. Krohne et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Investigating the Movement of Intravitreal Human Serum Albumin Nanoparticles in the Vitreous and Retina
- (2008) Hyuncheol Kim et al. PHARMACEUTICAL RESEARCH
- Safety Evaluation of Ocular Drug Delivery Formulations: Techniques and Practical Considerations
- (2008) Brian G. Short TOXICOLOGIC PATHOLOGY
- Retinal Precursors and the Development of Geographic Atrophy in Age-Related Macular Degeneration
- (2007) Michael L. Klein et al. OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now